Aleva Neurotherapeutics Raises USD 18 Million in Series C Financing Round

Aleva Neurotherapeutics Raises USD 18 Million in Series C Financing Round

Aleva Neurotherapeutics, a leading company developing next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s Disease and Essential Tremor, today announced that it has raised USD 18 million in a Series C financing round. In total, Aleva has raised USD 42 million from renowned private and institutional investors.

 

Read more